Quantinno Capital Management LP increased its holdings in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 687.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 155,033 shares of the company's stock after buying an additional 135,338 shares during the period. Quantinno Capital Management LP owned about 0.11% of Perrigo worth $3,986,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Barclays PLC grew its position in shares of Perrigo by 44.8% in the 3rd quarter. Barclays PLC now owns 120,502 shares of the company's stock valued at $3,160,000 after buying an additional 37,268 shares during the last quarter. Nisa Investment Advisors LLC increased its position in Perrigo by 10.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 304,948 shares of the company's stock valued at $7,840,000 after purchasing an additional 28,843 shares during the period. SG Americas Securities LLC bought a new position in Perrigo during the 4th quarter worth approximately $691,000. Janney Montgomery Scott LLC lifted its position in shares of Perrigo by 39.1% in the 4th quarter. Janney Montgomery Scott LLC now owns 90,624 shares of the company's stock worth $2,330,000 after purchasing an additional 25,472 shares during the period. Finally, Sound Income Strategies LLC boosted its stake in shares of Perrigo by 28.6% in the 4th quarter. Sound Income Strategies LLC now owns 482,811 shares of the company's stock valued at $12,413,000 after purchasing an additional 107,427 shares during the last quarter. 95.91% of the stock is owned by institutional investors.
Perrigo Trading Down 1.9%
PRGO traded down $0.51 during trading on Thursday, hitting $26.41. The company's stock had a trading volume of 911,814 shares, compared to its average volume of 1,525,632. The firm has a market capitalization of $3.63 billion, a P/E ratio of -22.57 and a beta of 0.45. Perrigo Company plc has a twelve month low of $23.14 and a twelve month high of $30.93. The stock's fifty day moving average price is $26.25 and its 200-day moving average price is $26.18. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94.
Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.04. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same quarter in the previous year, the business posted $0.29 EPS. Perrigo's revenue for the quarter was down 3.5% compared to the same quarter last year. Analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current year.
Perrigo Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th will be given a dividend of $0.29 per share. The ex-dividend date is Friday, May 30th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.39%. Perrigo's dividend payout ratio (DPR) is presently -88.55%.
Analyst Ratings Changes
Separately, Wall Street Zen lowered shares of Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $33.00.
Check Out Our Latest Stock Report on Perrigo
Insider Activity
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the firm's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the transaction, the executive vice president now directly owns 33,666 shares of the company's stock, valued at approximately $923,795.04. This trade represents a 18.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.70% of the stock is currently owned by company insiders.
About Perrigo
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Stories

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.